|
Volumn 13, Issue 14, 1999, Pages 1998-2001
|
Spanish consensus conference on drug resistance testing in clinical practice [16]
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CLINICAL PRACTICE;
COST BENEFIT ANALYSIS;
DRUG RESISTANCE;
GENOTYPE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
OCCUPATIONAL EXPOSURE;
PHENOTYPE;
POINT MUTATION;
PREGNANCY;
PRIORITY JOURNAL;
SEROCONVERSION;
SPAIN;
VIRUS PARTICLE;
DRUG RESISTANCE, MICROBIAL;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
SPAIN;
|
EID: 0032712264
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-199910010-00037 Document Type: Letter |
Times cited : (16)
|
References (30)
|